title: High disease activity of ankylosing spondylitis in the community before the introduction of tumour necrosis factor blockers.
authors.forename: Josef
authors.initials: J
authors.lastname: Hermann
authors.forename: Thomas
authors.initials: T
authors.lastname: Müller
authors.forename: Babak
authors.initials: B
authors.lastname: Yazdani-Biuki
authors.forename: Martin
authors.initials: M
authors.lastname: Aringer
authors.forename: Manfred
authors.initials: M
authors.lastname: Herold
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Ebner
authors.forename: Petra
authors.initials: P
authors.lastname: Ofner
authors.forename: Winfried
authors.initials: W
authors.lastname: Graninger
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003153:Community Health Services; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha